Hartung HP - Search Results

1

Correction to: The current standing of autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis.

Willison AG, Ruck T, Lenz G, Hartung HP, Meuth SG. Willison AG, et al. Among authors: hartung hp. J Neurol. 2022 Jul;269(7):3959-3961. doi: 10.1007/s00415-022-11158-z. J Neurol. 2022. PMID: 35608660 Free PMC article. No abstract available.

2

Current disease-modifying therapies in multiple sclerosis.

Kieseier BC, Hartung HP. Kieseier BC, et al. Among authors: hartung hp. Semin Neurol. 2003 Jun;23(2):133-46. doi: 10.1055/s-2003-41138. Semin Neurol. 2003. PMID: 12894379 Review.

3

Are statins a treatment option for multiple sclerosis?

Neuhaus O, Stüve O, Zamvil SS, Hartung HP. Neuhaus O, et al. Among authors: hartung hp. Lancet Neurol. 2004 Jun;3(6):369-71. doi: 10.1016/S1474-4422(04)00770-7. Lancet Neurol. 2004. PMID: 15157852 Review.

4

Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis.

Cepok S, Rosche B, Grummel V, Vogel F, Zhou D, Sayn J, Sommer N, Hartung HP, Hemmer B. Cepok S, et al. Among authors: hartung hp. Brain. 2005 Jul;128(Pt 7):1667-76. doi: 10.1093/brain/awh486. Epub 2005 Mar 30. Brain. 2005. PMID: 15800022

5

Immune response to immunotherapy: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosis.

Hemmer B, Stüve O, Kieseier B, Schellekens H, Hartung HP. Hemmer B, et al. Among authors: hartung hp. Lancet Neurol. 2005 Jul;4(7):403-12. doi: 10.1016/S1474-4422(05)70117-4. Lancet Neurol. 2005. PMID: 15963443 Review.

6

Mitoxantrone in multiple sclerosis.

Neuhaus O, Kieseier BC, Hartung HP. Neuhaus O, et al. Among authors: hartung hp. Adv Neurol. 2006;98:293-302. Adv Neurol. 2006. PMID: 16400840 Review. No abstract available.

7

Interferon-beta and neuroprotection in multiple sclerosis--facts, hopes and phantasies.

Kieseier BC, Hartung HP. Kieseier BC, et al. Among authors: hartung hp. Exp Neurol. 2007 Jan;203(1):1-4. doi: 10.1016/j.expneurol.2006.09.007. Epub 2006 Oct 25. Exp Neurol. 2007. PMID: 17069803 Review. No abstract available.

8

Inhibition by mitoxantrone of in vitro migration of immunocompetent cells: a possible mechanism for therapeutic efficacy in the treatment of multiple sclerosis.

Kopadze T, Dehmel T, Hartung HP, Stüve O, Kieseier BC. Kopadze T, et al. Among authors: hartung hp. Arch Neurol. 2006 Nov;63(11):1572-8. doi: 10.1001/archneur.63.11.1572. Arch Neurol. 2006. PMID: 17101825

9

Treatment and treatment trials in multiple sclerosis.

Kieseier BC, Wiendl H, Hemmer B, Hartung HP. Kieseier BC, et al. Among authors: hartung hp. Curr Opin Neurol. 2007 Jun;20(3):286-93. doi: 10.1097/WCO.0b013e3281568b80. Curr Opin Neurol. 2007. PMID: 17495622 Review.

10

Early MRI changes in a mouse model of multiple sclerosis are predictive of severe inflammatory tissue damage.

Nessler S, Boretius S, Stadelmann C, Bittner A, Merkler D, Hartung HP, Michaelis T, Brück W, Frahm J, Sommer N, Hemmer B. Nessler S, et al. Among authors: hartung hp. Brain. 2007 Aug;130(Pt 8):2186-98. doi: 10.1093/brain/awm105. Epub 2007 Jul 7. Brain. 2007. PMID: 17617655

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,138 results

Search Page

Filters